Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Pathogenesis of FUS-associated ALS and FTD: insights from rodent models.

Nolan M, Talbot K, Ansorge O.

Acta Neuropathol Commun. 2016 Sep 6;4(1):99. doi: 10.1186/s40478-016-0358-8. Review.

2.

Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort.

Murphy J, Factor-Litvak P, Goetz R, Lomen-Hoerth C, Nagy PL, Hupf J, Singleton J, Woolley S, Andrews H, Heitzman D, Bedlack RS, Katz JS, Barohn RJ, Sorenson EJ, Oskarsson B, Fernandes Filho JA, Kasarskis EJ, Mozaffar T, Rollins YD, Nations SP, Swenson AJ, Koczon-Jaremko BA, Mitsumoto H; ALS COSMOS.

Neurology. 2016 Mar 1;86(9):813-20. doi: 10.1212/WNL.0000000000002305. Epub 2016 Jan 22.

PMID:
26802094
3.

Executive Dysfunctions and Event-Related Brain Potentials in Patients with Amyotrophic Lateral Sclerosis.

Seer C, Fürkötter S, Vogts MB, Lange F, Abdulla S, Dengler R, Petri S, Kopp B.

Front Aging Neurosci. 2015 Dec 18;7:225. doi: 10.3389/fnagi.2015.00225. eCollection 2015.

4.

Symptom Management and End-of-Life Care in Amyotrophic Lateral Sclerosis.

Jackson CE, McVey AL, Rudnicki S, Dimachkie MM, Barohn RJ.

Neurol Clin. 2015 Nov;33(4):889-908. doi: 10.1016/j.ncl.2015.07.010. Review.

PMID:
26515628
5.

Modeling ALS and FTD with iPSC-derived neurons.

Lee S, Huang EJ.

Brain Res. 2015 Oct 14. pii: S0006-8993(15)00740-4. doi: 10.1016/j.brainres.2015.10.003. [Epub ahead of print] Review.

6.

Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease.

Rosenfeld J, Strong MJ.

Neurotherapeutics. 2015 Apr;12(2):317-25. doi: 10.1007/s13311-014-0332-8. Review.

7.

Spectrum of cognitive impairment in Korean ALS patients without known genetic mutations.

Oh SI, Park A, Kim HJ, Oh KW, Choi H, Kwon MJ, Ki CS, Kim HT, Kim SH.

PLoS One. 2014 Feb 3;9(2):e87163. doi: 10.1371/journal.pone.0087163. eCollection 2014.

8.
9.

Multiparametric MRI study of ALS stratified for the C9orf72 genotype.

Bede P, Bokde AL, Byrne S, Elamin M, McLaughlin RL, Kenna K, Fagan AJ, Pender N, Bradley DG, Hardiman O.

Neurology. 2013 Jul 23;81(4):361-9. doi: 10.1212/WNL.0b013e31829c5eee. Epub 2013 Jun 14.

10.

Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis.

Ravits J, Appel S, Baloh RH, Barohn R, Brooks BR, Elman L, Floeter MK, Henderson C, Lomen-Hoerth C, Macklis JD, McCluskey L, Mitsumoto H, Przedborski S, Rothstein J, Trojanowski JQ, van den Berg LH, Ringel S.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14 Suppl 1:5-18. doi: 10.3109/21678421.2013.778548.

11.

Behavior matters--cognitive predictors of survival in amyotrophic lateral sclerosis.

Hu WT, Shelnutt M, Wilson A, Yarab N, Kelly C, Grossman M, Libon DJ, Khan J, Lah JJ, Levey AI, Glass J.

PLoS One. 2013;8(2):e57584. doi: 10.1371/journal.pone.0057584. Epub 2013 Feb 27.

12.

The Relationship between Depressive Symptoms, Disease State, and Cognition in Amyotrophic Lateral Sclerosis.

Jelsone-Swain L, Persad C, Votruba KL, Weisenbach SL, Johnson T, Gruis KL, Welsh RC.

Front Psychol. 2012 Dec 17;3:542. doi: 10.3389/fpsyg.2012.00542. eCollection 2012.

13.

ALS and Frontotemporal Dysfunction: A Review.

Achi EY, Rudnicki SA.

Neurol Res Int. 2012;2012:806306. doi: 10.1155/2012/806306. Epub 2012 Aug 7.

14.

Predictors of emergent feeding tubes and tracheostomies in amyotrophic lateral sclerosis (ALS).

Tsou AY, Karlawish J, McCluskey L, Xie SX, Long JA.

Amyotroph Lateral Scler. 2012 May;13(3):318-25. doi: 10.3109/17482968.2012.662987.

15.

ApoE and TDP-43 neuropathology in two siblings with familial FTLD-motor neuron disease.

Vossel KA, Bien-Ly N, Bernardo A, Rascovsky K, Karydas A, Rabinovici GD, Sidhu M, Huang EJ, Miller BL, Huang Y, Seeley WW.

Neurocase. 2013;19(3):295-301. doi: 10.1080/13554794.2012.667124. Epub 2012 Apr 18.

16.

Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis.

Brettschneider J, Libon DJ, Toledo JB, Xie SX, McCluskey L, Elman L, Geser F, Lee VM, Grossman M, Trojanowski JQ.

Acta Neuropathol. 2012 Mar;123(3):395-407. doi: 10.1007/s00401-011-0932-x. Epub 2012 Jan 1.

17.

Predicting survival in frontotemporal dementia with motor neuron disease.

Coon EA, Sorenson EJ, Whitwell JL, Knopman DS, Josephs KA.

Neurology. 2011 May 31;76(22):1886-93. doi: 10.1212/WNL.0b013e31821d767b.

18.

Cognitive and behavioral challenges in caring for patients with frontotemporal dementia and amyotrophic lateral sclerosis.

Merrilees J, Klapper J, Murphy J, Lomen-Hoerth C, Miller BL.

Amyotroph Lateral Scler. 2010 May 3;11(3):298-302. doi: 10.3109/17482961003605788.

19.

Prognostic factors in ALS: A critical review.

Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, Traynor BG; Eurals Consortium.

Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):310-23. doi: 10.3109/17482960802566824. Review.

20.

Survival profiles of patients with frontotemporal dementia and motor neuron disease.

Hu WT, Seelaar H, Josephs KA, Knopman DS, Boeve BF, Sorenson EJ, McCluskey L, Elman L, Schelhaas HJ, Parisi JE, Kuesters B, Lee VM, Trojanowski JQ, Petersen RC, van Swieten JC, Grossman M.

Arch Neurol. 2009 Nov;66(11):1359-64. doi: 10.1001/archneurol.2009.253.

Items per page

Supplemental Content

Write to the Help Desk